Addition of rituximab to TBI/CY improves the outcome of first-line autologous stem cell transplantation for mantle cell lymphoma

被引：0
|
作者：
Seyfarth, B
Boehme, V
Stuhlmann, R
Sonnen, R
Kneba, M
Schmitz, N
Dreger, P
机构：
[1] Allgemein Krankenhaus St Georg, Hamburg, Germany
[2] Univ Schleswig Holstein, Kiel, Germany
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [31] Characteristics and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma
    Dietrich, S.
    Tielesch, B.
    Rieger, M.
    Nickelsen, M.
    Pott, C.
    Witzens-Harig, M.
    Kneba, M.
    Ho, A. D.
    Schmitz, N.
    Dreger, P.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S246 - S246
  • [32] COST EFFECTIVENESS OF BORTEZOMIB, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE FOR THE FIRST-LINE TREATMENT OF MANTLE CELL LYMPHOMA PATIENTS NOT ELIGIBLE FOR STEM CELL TRANSPLANTATION
    van Keep, M.
    Gairy, K.
    Seshagiri, D.
    Thilakarathne, P.
    Lee, D.
    HAEMATOLOGICA, 2015, 100 : 148 - 148
  • [33] First Line Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma (MCL)
    Lachance, Silvy
    Molucon-Chabrot, Cecile
    Busque, Lambert
    Kiss, Thomas
    Cohen, Sandra
    Roy, Denis-Claude
    Roy, Jean
    Sauvageau, Guy
    BLOOD, 2009, 114 (22) : 1307 - 1307
  • [34] Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma
    Jain, Preetesh
    Zhao, Shuangtao
    Lee, Hun Ju
    Hill, Holly A.
    Ok, Chi Young
    Kanagal-Shamanna, Rashmi
    Hagemeister, Fredrick B.
    Fowler, Nathan
    Fayad, Luis
    Yao, Yixin
    Liu, Yang
    Moghrabi, Omar B.
    Navsaria, Lucy
    Feng, Lei
    Gonzalez, Graciela M. Nogueras
    Xu, Guofan
    Thirumurthi, Selvi
    Santos, David
    Iliescu, Cezar
    Tang, Guilin
    Medeiros, L. Jeffrey
    Vega, Francisco
    Avellaneda, Michelle
    Badillo, Maria
    Flowers, Christopher R.
    Wang, Linghua
    Wang, Michael L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (02) : 202 - +
  • [35] Autologous stem cell transplantation in patients with mantle cell lymphoma
    Oinonen, R
    Jantunen, E
    Itälä, M
    Lehtinen, T
    Kuittinen, O
    Franssila, K
    Wiklund, T
    Elonen, E
    LEUKEMIA & LYMPHOMA, 2002, 43 (06) : 1229 - 1237
  • [36] AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR MANTLE CELL LYMPHOMA
    Mabindra, A.
    Copelan, E.
    Bolwell, B.
    Rybicki, L.
    Dean, R.
    Kalaycio, M.
    Sobecks, R.
    Ferraro, C.
    Cherni, K.
    Pohlman, B.
    Sweetenham, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 64 - 65
  • [37] Autologous hematopoietic stem cell transplantation for mantle cell lymphoma
    Vose, JM
    Bierman, PJ
    Weisenburger, DD
    Lynch, JC
    Bociek, G
    Chan, WC
    Greiner, TC
    Armitage, JO
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (06) : 640 - 645
  • [38] Double autologous stem cell transplantation in mantle cell lymphoma
    Bolaman, Z
    Kadikoylu, G
    Barutca, S
    Senturk, T
    TRANSPLANTATION, 2002, 74 (06) : 902 - 903
  • [39] Benefit of rituximab maintenance after first-line bendamustine-rituximab in mantle cell lymphoma
    Wang, Yucai
    Larson, Melissa C.
    Kumar, Anita
    Hill, Brian T.
    Bond, David Alan
    Kahl, Brad S.
    Danilov, Alexey Valeryevich
    Merryman, Reid
    Grover, Natalie Sophia
    Tun, Aung M.
    Ayyappan, Sabarish Ram
    Pongas, Georgios
    Portell, Craig Anthony
    Munoz, Javier
    Reagan, Patrick Michael
    Moustafa, Muhamad Alhaj
    Pophali, Priyanka Avinash
    Greenwell, Irl Brian
    Cohen, Jonathon Brett
    Martin, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Clinical outcome of autologous stem cell transplantation as first-line treatment in 30 patients with high risk lymphoblastic lymphoma
    黄文阳
    China Medical Abstracts(Internal Medicine), 2014, 31 (02) : 121 - 121
12345